Procept BioRobotics公司周二盘后股价大涨5.24%,引发市场关注。
公司此前公布了截至12月31日的2024财年第四季度财报,每股亏损0.35美元,高于分析师平均预期的0.33美元亏损。不过营收同比大增56.6%至6824万美元,高于预期的6678万美元。
尽管业绩不及预期,但Procept BioRobotics的股价在盘后仍出现大涨。一些分析人士认为,市场对该公司长期增长潜力保持乐观,业绩短期低于预期影响有限。另外该股此前走势持续疲软,获利回吐需求较大。总的来说,公司具备医疗机器人等前景广阔的业务发展方向,中长期增长预期良好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.